Chemoinformaics analysis of Indolopyridoquinazoline
| Molecular Weight | 270.295 | nRot | 0 |
| Heavy Atom Molecular Weight | 260.215 | nRig | 25 |
| Exact Molecular Weight | 270.091 | nRing | 5 |
| Solubility: LogS | -5.421 | nHRing | 3 |
| Solubility: LogP | 3.265 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 5 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 3 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 4 | No. of Arom Atom | 21 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 25 |
| nHA | 3 | APOL | 39.4579 |
| nHD | 1 | BPOL | 14.0221 |
| QED | 0.435 |
| Synth | 2.39 |
| Natural Product Likeliness | -0.428 |
| NR-PPAR-gamma | 0.976 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.112 |
| Pgp-sub | 0.153 |
| HIA | 0.029 |
| CACO-2 | -4.995 |
| MDCK | 0.0000165 |
| BBB | 0.74 |
| PPB | 0.96647 |
| VDSS | 2.495 |
| FU | 0.0189222 |
| CYP1A2-inh | 0.997 |
| CYP1A2-sub | 0.2 |
| CYP2c19-inh | 0.834 |
| CYP2c19-sub | 0.104 |
| CYP2c9-inh | 0.464 |
| CYP2c9-sub | 0.804 |
| CYP2d6-inh | 0.797 |
| CYP2d6-sub | 0.859 |
| CYP3a4-inh | 0.956 |
| CYP3a4-sub | 0.244 |
| CL | 5.533 |
| T12 | 0.481 |
| hERG | 0.646 |
| Ames | 0.916 |
| ROA | 0.649 |
| SkinSen | 0.945 |
| Carcinogencity | 0.107 |
| EI | 0.918 |
| Respiratory | 0.984 |
| NR-Aromatase | 0.962 |
| Antiviral | Yes |
| Prediction | 0.539075 |